Transition Therapeutics Profile

Transition Therapeutics Inc., a biopharmaceutical company, researches and develops therapeutic agents for disease indications primarily in Canada. more
NameTransition Therapeutics
Chairman and CEOTony CruzView All
Macroaxis Advice
InstrumentCanada Stock View All
Business AddressToronto, ON MG L
ExchangeToronto Stock Exchange
Phone416 260 7770
CurrencyCAD - Canadian Dollar

Transition Therapeutics Directors

Transition Therapeutics Corporate Directors

Christopher Henley Independent Director
Gary Pace Independent Director
Paul Baehr Independent Director
Also please take a look at World Market Map. Please also try Transaction History module to view history of all your transactions and understand their impact on performance.